Both in Pharmaceuticals
Assembly Biosciences vs Arvinas
Over the past year ASMB returned −4.7% and ARVN returned −12.1%; their daily moves had a correlation of 0.26.
ASMB −4.7% ARVN −12.1%Growth of $1, one year, split-adjusted
| Metric | ASMB | ARVN |
|---|---|---|
| Price | $23.48 | $7.50 |
| Market cap | $478.1M | $490.4M |
| Today | −0.55% | −0.13% |
| 1 month | −31.1% | −18.3% |
| 6 months | −11.9% | −26.3% |
| Year to date | −31.0% | −36.8% |
| 1 year | −4.8% | −9.3% |
| Revenue growth (YoY) | +38.9% | +1014.7% |
| Gross margin | 100.0% | 96.4% |
| Net margin | −28.8% | 67.8% |
| P/E (TTM) | — | 52.7× |
| Price / sales | 6.4× | 1.5× |
| Net cash | $320.4M | $567.6M |
| Dividend yield | — | — |
| Volatility (60d) | 61.3% | 46.1% |
| Short % of float | 19.3% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).